A promising inactivated whole-virion SARS-CoV-2 vaccine

Lancet Infect Dis. 2021 Jan;21(1):2-3. doi: 10.1016/S1473-3099(20)30832-X. Epub 2020 Oct 15.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects
  • COVID-19 Vaccines / immunology*
  • Clinical Trials as Topic
  • Humans
  • Middle Aged
  • SARS-CoV-2 / immunology*
  • Vaccines, Inactivated / immunology
  • Virion / immunology*
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Vaccines, Inactivated